Sierra Capital LLC grew its position in ARK Genomic Revolution ETF (NYSEARCA:ARKG – Get Rating) by 22.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,226 shares of the company’s stock after buying an additional 14,669 shares during the quarter. Sierra […]
Emerald Advisers LLC acquired a new position in shares of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,696 shares of the company’s stock, valued at approximately $104,000. Other hedge funds also recently added […]
SignalPoint Asset Management LLC trimmed its holdings in shares of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG – Get Rating) by 26.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,730 shares of the company’s stock after selling 2,426 shares during […]
SignalPoint Asset Management LLC reduced its stake in ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG – Get Rating) by 26.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,730 shares of the company’s stock after selling 2,426 shares during the quarter. SignalPoint […]
Transcend Wealth Collective LLC raised its stake in ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG – Get Rating) by 25.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,367 shares of the company’s stock after acquiring an additional 1,701 shares during the period. Transcend […]